Industry

Assemblywomen Shanique Speight Introduces 11 Bills Supporting Menstrual Education Including Endometriosis NEW YORK–(BUSINESS WIRE)–The Endometriosis Foundation of America (EndoFound) is working with New Jersey Assemblywoman Shanique Speight (NJ-29th Legislative District) to create awareness and support for her 2022 menstrual health bills focusing on early endometriosis education and intervention. On Tuesday, June 21, at 11 AM … [Read more…]

– Two Oral Presentations and 22 Posters Will Be Presented Across HDV, HCV, HBV, NASH and PSC – – Oral Presentations of Latest Phase 3 Hepcludex® (bulevirtide) Efficacy and Safety and Patient-Reported Outcomes Data Reinforce the Clinical Importance of the First-in-Class Treatment for HDV – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq:GILD) today announced that … [Read more…]

DALLAS & OWINGS MILLS, Md.–(BUSINESS WIRE)–United Surgical Partners International (USPI), the largest ambulatory platform in the country and a subsidiary of Tenet Healthcare (NYSE: THC), and United Urology Group (UUG), one of the nation’s largest networks of urology affiliate practices, today signed a definitive agreement to form a joint venture partnership in 22 ambulatory surgery … [Read more…]

– STELLAR-303 is the first phase 3 pivotal trial evaluating XL092, a next-generation oral tyrosine kinase inhibitor – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced the initiation of STELLAR-303, a phase 3 pivotal trial evaluating XL092 in combination with atezolizumab versus regorafenib in patients with metastatic colorectal cancer (CRC) that is not microsatellite instability-high … [Read more…]

LEWISVILLE, Texas–(BUSINESS WIRE)–CareView Communications, Inc. (“CareView” or the “Company”) (OTCQB: CRVW), an information technology provider to the healthcare industry, has been selected to exhibit the CareView Patient Safety System®, including its patented, predictive Virtual Bed Rails® and Virtual Chair Rails® technology, at the Vizient Innovative Technology Exchange. Vizient, Inc., the nation’s largest member-driven health care … [Read more…]

Respected leaders bring deep industry expertise and diverse perspectives to further enable company’s substantial growth CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced the appointment of Henrietta Fore and Stacy Enxing Seng to the company’s Board of Directors, effective immediately. “The addition of Henrietta and Stacy to Imperative Care’s Board of Directors will prove invaluable as … [Read more…]

Provost & Chief Academic Officer of Howard University brings scientific experience and new perspectives on the consequences of sickle cell disease FORT COLLINS, Colo.–(BUSINESS WIRE)–Cetya Therapeutics, Inc. today announced the addition of Dr. Anthony Wutoh, Provost and Chief Academic Officer of Howard University, to its Board of Directors. Dr. Wutoh received a B.A. in Biochemistry … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–$DFCO #BrianBonar–An innovator in clean energy, healthcare, and technology, Dalrada Financial Corporation (OTCQB: DFCO, “Dalrada Financial Corporation,” “Dalrada”) announced the expansion of its executive leadership team naming Brian McGoff as President and Chief Operating Officer. Mr. McGoff’s achievements include implementing cost-effective strategies for executing domestic and international growth, building strong teams, and delivering … [Read more…]

Borrowing capacity increases by $175 million Base interest rate fixed on $150 million HOUSTON–(BUSINESS WIRE)–U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced the closing of a $325 million, five-year credit facility that includes a $150 million … [Read more…]

– Preclinical data show synergistic protective effect of anti-protein and anti-polysaccharide antibodies in a highly virulent model of serotype 3 invasive pneumococcal disease – – Presentation at the 12th International Symposium on Pneumococci and Pneumococcal Diseases – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Affinivax, Inc. (“Affinivax”), a clinical stage biopharmaceutical company pioneering the development of a novel class of … [Read more…]